JP Morgan Chase
FOLD

JP Morgan Chase’s Amicus Therapeutics FOLD Stock Holding History

JP Morgan Chase’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33,900
Closed -$336K – 7496
2024
Q2 		$336K Hold
33,900
– – ﹤0.01% 4891
2024
Q1 		$399K Buy
+33,900
New +$434K ﹤0.01% 4945
2021
Q1 		– Sell
-257,500
Closed -$5.95M – 6152
2020
Q4 		$5.95M Buy
257,500
+27,500
+12% +$562K ﹤0.01% 2650
2020
Q3 		$3.24M Buy
230,000
+68,900
+43% +$1M ﹤0.01% 2901
2020
Q2 		$2.43M Buy
161,100
+140,000
+664% +$1.71M ﹤0.01% 2974
2020
Q1 		$195K Sell
21,100
-18,900
-47% -$180K ﹤0.01% 4279
2019
Q4 		$390K Buy
+40,000
New +$366K ﹤0.01% 4364
2019
Q3 		– Sell
-40,000
Closed -$480K – 5803
2019
Q2 		$480K Sell
40,000
-250,000
-86% -$3.17M ﹤0.01% 4263
2019
Q1 		$3.94M Buy
+290,000
New +$3.54M ﹤0.01% 2786
2018
Q4 		– Sell
-550,000
Closed -$6.65M – 5751
2018
Q3 		$6.65M Buy
550,000
+310,000
+129% +$4.34M ﹤0.01% 2514
2018
Q2 		$3.75M Buy
240,000
+150,000
+167% +$2.27M ﹤0.01% 2915
2018
Q1 		$1.35M Sell
90,000
-10,000
-10% -$152K ﹤0.01% 3507
2017
Q4 		$1.44M Buy
+100,000
New +$1.37M ﹤0.01% 3518
2017
Q3 		– Sell
-40,000
Closed -$403K – 5028
2017
Q2 		$403K Buy
+40,000
New +$322K ﹤0.01% 3806
2016
Q3 		– Sell
-70,000
Closed -$382K – 4628
2016
Q2 		$382K Buy
+70,000
New +$490K ﹤0.01% 3543

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

JP Morgan Chase's FOLD Position: Q2 2026 in Review

JP Morgan Chase sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 6,749,190 shares — an estimated $97.4M sold.

JP Morgan Chase first reported a position in FOLD in Q2 2013 and held it in 45 quarters. The position peaked at $253M in Q4 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • JP Morgan Chase reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 6,749,190 Amicus Therapeutics shares in Q2 2026, an estimated $97.4M.
  • JP Morgan Chase first reported a position in Amicus Therapeutics in Q2 2013 and held it in 45 quarters.
  • JP Morgan Chase's Amicus Therapeutics position peaked at $253M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.